IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT)

21 filings reported holding IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.2M shares of 68.2M outstanding shares and own 38.37% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (6.17M shares), Novo Holdings A/S (4.43M shares), Samsara BioCapital, LLC (3.64M shares), PFM Health Sciences, LP (2.34M shares), MARSHALL WACE, LLP (2.11M shares), MORGAN STANLEY (1.97M shares), BANK OF AMERICA CORP /DE/ (1.65M shares), ARMISTICE CAPITAL, LLC (1.55M shares), Pivotal bioVenture Partners Investment Advisor LLC (864K shares), and Logos Global Management LP (494K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.